
RYSE Asset Management
Europe, England, United Kingdom, London'%3e%3cpath fill='%23012169' d='M0 0v30h60V0z'/%3e%3cpath stroke='%23fff' stroke-width='6' d='m0 0 60 30m0-30L0 30'/%3e%3cpath stroke='%23C8102E' stroke-width='4' d='m0 0 60 30m0-30L0 30' clip-path='url(%23b)'/%3e%3cpath stroke='%23fff' stroke-width='10' d='M30 0v30M0 15h60'/%3e%3cpath stroke='%23C8102E' stroke-width='6' d='M30 0v30M0 15h60'/%3e%3c/g%3e%3c/svg%3e)
Description
Getting to the Future First. Since 2015, RYSE is one of Europe’s leading firms for health, technology, and impact.
Investor Profile
RYSE Asset Management has made 14 investments, with 1 in the past 12 months and 14% as lead.
Stage Focus
- Non Equity Assistance (50%)
- Series Unknown (29%)
- Pre Seed (14%)
- Series A (7%)
Country Focus
- United Kingdom (71%)
- United States (14%)
- Portugal (7%)
- Spain (7%)
Industry Focus
- Health Care
- Software
- Medical
- Apps
- Information Technology
- Artificial Intelligence (Ai)
- Health Diagnostics
- Mhealth
- Therapeutics
- Electronic Health Record (Ehr)
FAQ
Frequently Asked Questions
Learn who this investor regularly partners with—both firms and angels—and explore their latest activity.